Showing results (1771-1780 of 1,902) with videos related to

Sort By:
Pageof 191
Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2016
Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue EngineeringColin R Butler, Robert E Hynds, Kate H C Gowers, et al.
Journal of Veterinary Internal Medicine|October 6, 2023
Novel genomic prognostic biomarkers for dogs with cancerEsther Chon, Sharadha Sakthikumar, Min Tang, et al.
Nucleic Acids Research|January 2, 2015
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypesPeter Sykora, Magdalena Misiak, Yue Wang, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Cancer Medicine|March 24, 2022
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathyXindi Zhang, Matthew R Trendowski, Emma Wilkinson, et al.
BMJ Open Diabetes Research & Care|February 27, 2026
Management and outcomes of people presenting with new diabetes-related foot infections: a prospective observational study from Australia and New ZealandEdward Raby, Laurens Manning, Kate McCarthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based ChemotherapyChunkit Fung, Howard D Sesso, Annalynn M Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.
Pageof 191